Market Movers Archives | Page 186 of 871 | Smartkarma

Alibaba Pictures Group (1060)

0.78 HKD +0.02 (+2.63%) Volume: 687.43M

Alibaba Pictures Group’s stock price stands strong at 0.78 HKD, marking a noteworthy trading session increase of +2.63%, backed by a substantial trading volume of 687.43M. With an impressive YTD growth of +64.21%, the 1060 stock continues to demonstrate a promising performance in the market.

Latest developments on Alibaba Pictures Group

Alibaba Pictures‘ stock price saw fluctuations today following a series of key events. The company announced a new partnership with a major film studio, which boosted investor confidence in its future growth potential. However, concerns arose after reports of a delay in the release of a highly anticipated blockbuster film. This uncertainty led to some investors selling off their shares, causing the stock price to dip temporarily. Despite this setback, analysts remain optimistic about Alibaba Pictures‘ long-term prospects, citing its strong track record in the entertainment industry.

A look at Alibaba Pictures Group Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Alibaba Pictures Group Ltd. has a promising long-term outlook based on its Smartkarma Smart Scores. With a strong score of 5 for Growth and Momentum, the company is positioned for significant expansion and positive market performance. This indicates that Alibaba Pictures is likely to experience steady growth and maintain its upward momentum in the industry.

While the company’s Dividend score is lower at 1, its Value and Resilience scores of 3 and 4, respectively, suggest a solid foundation and ability to withstand market fluctuations. Overall, Alibaba Pictures appears to be well-equipped to capitalize on opportunities for growth and innovation in the television and motion picture industry in China.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Horizon Robotics (9660)

7.60 HKD -0.21 (-2.69%) Volume: 200.17M

Horizon Robotics’s stock price is currently at 7.60 HKD, experiencing a slight dip of -2.69% this trading session, with a substantial trading volume of 200.17M. Despite today’s decline, the company has seen a remarkable YTD increase of +111.11%, reflecting its robust market performance.

Latest developments on Horizon Robotics

Horizon Robotics, a leading AI chip startup, saw its stock price surge today following the announcement of a new partnership with a major automaker to develop autonomous driving technology. This collaboration comes on the heels of Horizon Robotics securing a significant round of funding from top investors last week, signaling confidence in the company’s growth potential. The stock price movement reflects the market’s positive response to these key events, highlighting Horizon Robotics‘ position as a key player in the rapidly evolving AI chip industry.

Horizon Robotics on Smartkarma

Analysts on Smartkarma are closely monitoring Horizon Robotics as the company approaches key milestones. Dimitris Ioannidis predicts that the IPO lock-up expiries of disclosed and undisclosed shareholders will boost the free float from 10% to 70%, leading to global index inclusion in June 2025 and February 2026. On the other hand, Andrei Zakharov believes that Horizon Robotics shares may underperform as the IPO lock-up expires in April, unlocking a significant amount of shares. This contrasting sentiment from analysts reflects the uncertainty surrounding Horizon Robotics as it navigates the post-IPO landscape.

Furthermore, Brian Freitas highlights Horizon Robotics‘ potential inclusion in various indices, such as the Hang Seng Composite Index (HSCI) and the Hang Seng Internet & Information Technology Index (HSIII Index). With 29 adds and 41 deletes for the HSCI in March, the company is expected to be added to Stock Connect in May. This coverage underscores the importance of index rebalances and market dynamics in shaping the future trajectory of Horizon Robotics in the competitive tech landscape.

A look at Horizon Robotics Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Horizon Robotics, Inc. has received positive Smart Scores across the board, with high ratings in Growth, Resilience, and Momentum. This indicates a bright long-term outlook for the company in terms of its ability to expand, adapt to challenges, and maintain a strong performance trajectory. With a focus on developing advanced driver assistance systems and autonomous driving solutions, Horizon Robotics is well-positioned to capitalize on the growing demand for smart technology in the automotive industry.

While Horizon Robotics may not score as high in terms of Value and Dividend, its strong ratings in Growth, Resilience, and Momentum suggest that the company’s innovative technology services and solutions for passenger vehicles in Hong Kong will continue to drive its success in the long run. Investors looking for a company with a solid growth potential and a resilient business model may find Horizon Robotics to be a promising opportunity for their portfolios.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Sino Biopharmaceutical (1177)

4.18 HKD -0.03 (-0.71%) Volume: 159.93M

Sino Biopharmaceutical’s stock price stands at 4.18 HKD, experiencing a minor dip of -0.71% this trading session, despite a robust trading volume of 159.93M shares. However, with a promising YTD percentage change of +30.62%, Sino Biopharmaceutical (1177) continues to exhibit strong performance in the market.

Latest developments on Sino Biopharmaceutical

Today, Sino Biopharmaceutical‘s stock price experienced significant movements following the announcement of their latest drug development milestones. The company revealed positive results from their clinical trials for a new cancer treatment, leading to a surge in investor confidence. This news comes after a series of strategic partnerships and acquisitions that have positioned Sino Biopharmaceutical as a key player in the pharmaceutical industry. Analysts are optimistic about the company’s future prospects and anticipate further growth in the coming months.

A look at Sino Biopharmaceutical Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Sino Biopharmaceutical Limited shows promising long-term potential in terms of momentum, with a score of 4. This indicates that the company is performing well in terms of market trends and investor sentiment, which could lead to continued growth in the future. Additionally, Sino Biopharmaceutical received a resilience score of 3, suggesting that the company is well-positioned to withstand economic downturns or industry challenges, providing stability for investors.

While Sino Biopharmaceutical‘s value, dividend, and growth scores are not as high as its momentum and resilience scores, the overall outlook for the company appears positive. With a focus on researching, developing, and selling biopharmaceutical products for various medical treatments, including ophthalmia and hepatitis, Sino Biopharmaceutical Limited is well-positioned to capitalize on the growing demand for innovative healthcare solutions in the market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

China Petroleum & Chemical (386)

4.19 HKD +0.04 (+0.96%) Volume: 153.59M

China Petroleum & Chemical’s stock price is currently at 4.19 HKD, with a positive trading session change of +0.96% on a high trading volume of 153.59M, despite a year-to-date percentage change of -5.84%, reflecting a dynamic performance in the market.

Latest developments on China Petroleum & Chemical

Today, China Petroleum & Chemical, also known as Sinopec, saw fluctuations in its stock price following key events in the energy sector. Australia Pacific LNG, in a move that could impact Sinopec’s profits, has cut prices in a significant supply deal. Additionally, Sinopec has partnered with Saudi Aramco’s unit in a $4 billion joint venture, further expanding its global presence. Furthermore, Sinopec’s affiliate recently sold exchangeable bonds backed by the company’s H shares, indicating strategic financial moves. The World Gas Conference predicts China’s gas demand to peak around 620 bcm between 2035 and 2040, suggesting potential future growth opportunities for Sinopec.

China Petroleum & Chemical on Smartkarma

Analyst John Ley from Smartkarma recently published a bullish research report on China Petroleum & Chemical. In his report titled “Sinopec (386) Earnings: Volatility Setup and Post-Release Price Behavior”, Ley analyzes Sinopec’s recent 8.47% drop and its implications on price patterns, implied volatility, and earnings outcomes. He notes that Q1 historically shows the second-largest price moves for the company, making it a crucial period to monitor for investors. Ley highlights the significance of implied vols in his analysis, pointing out their standout performance in various metrics compared to historical data.

For more insights on China Petroleum & Chemical and other investment opportunities, visit Smartkarma’s platform to access independent research reports from top analysts like John Ley. Stay informed about the latest market trends and make well-informed investment decisions based on expert analysis and insights provided by industry professionals on Smartkarma.

A look at China Petroleum & Chemical Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Petroleum & Chemical Corporation, also known as Sinopec, has a bright long-term outlook based on its impressive Smart Scores. With a top score in both Value and Dividend, the company is seen as a solid investment choice for those looking for stability and returns. Additionally, its strong Momentum score indicates that the company is performing well in the market, showing positive growth potential in the future.

While China Petroleum & Chemical scores slightly lower in Growth and Resilience, overall, the company’s Smart Scores paint a positive picture for its future prospects. As a major player in the production and trading of petroleum and petrochemical products in China, Sinopec’s diverse product offerings and extensive market reach position it well for continued success in the industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Topsports International Holdings (6110)

2.80 HKD -0.29 (-9.39%) Volume: 126.33M

Topsports International Holdings’s stock price stands at 2.80 HKD, experiencing a significant drop of -9.39% this trading session. With a hefty trading volume of 126.33M, the company’s stock performance has been underwhelming with a YTD percentage change of -6.04%. Stay updated with Topsports International Holdings (6110)’s stock price performance and market trends.

Latest developments on Topsports International Holdings

Topsports International Holdings is currently navigating a competitive landscape alongside industry giants Nike and Adidas, as they announce their final dividend for FY 2025. However, the company has reported a decline in annual profits, along with a sales decrease and store contraction in Q4 FY2024/25. Topsports has also revised annual caps in their logistics agreement with Li Xun, reflecting strategic adjustments in response to market challenges. These developments may be influencing the fluctuations in Topsports International Holdings stock price today.

A look at Topsports International Holdings Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Topsports International Holdings has a positive long-term outlook. With high scores in Growth, Resilience, and Momentum, the company is positioned well for future success. The Growth score indicates potential for expansion and increased market share, while the Resilience score suggests the company’s ability to withstand economic challenges. Additionally, the Momentum score reflects the company’s current positive trend in performance. Although the Value and Dividend scores are average, the overall outlook for Topsports International Holdings appears promising.

Topsports International Holdings Limited, a sports shoes and apparel retailer operating in China, has received favorable ratings in key areas crucial for long-term success. The company’s focus on selling sports shoes, sports shirts, and other related products positions it well in the Chinese market. With solid scores in Growth, Resilience, and Momentum, Topsports International Holdings is likely to continue its upward trajectory in the sports retail industry. While Value and Dividend scores are average, the company’s overall outlook remains positive based on the Smartkarma Smart Scores.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Petrochina (857)

6.48 HKD +0.07 (+1.09%) Volume: 123.43M

Petrochina’s stock price shows a promising uptick at 6.48 HKD, marking a positive trading session with a 1.09% increase and a robust trading volume of 123.43M. With a year-to-date percentage change of +6.06%, Petrochina (857) continues to deliver a strong performance on the stock market.

Latest developments on Petrochina

Today, PetroChina made headlines as it announced its upcoming Annual General Meeting, which will include key director elections. This news comes amidst falling Middle East Crude-Benchmarks due to a potential increase in OPEC+ supply. Despite this, returns at PetroChina (HKG:857) are on the rise, with Hang Pin Living Technology also expanding its investment in the company. These events have contributed to fluctuations in PetroChina‘s stock price, making it a focal point for investors monitoring the energy sector.

A look at Petrochina Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, PetroChina is looking at a positive long-term outlook. With high scores in Growth, Value, and Dividend, the company seems to be well-positioned for future success. Additionally, its Momentum score of 5 indicates strong performance in the market. However, its Resilience score of 3 suggests some potential vulnerabilities that investors should keep an eye on.

PetroChina Company Limited is involved in various aspects of the oil and gas industry, including exploration, production, refining, and distribution. With solid scores in key areas like Value and Dividend, the company appears to be a reliable investment option. Its strong Momentum score further reinforces its positive outlook for the future. Investors may want to monitor its Resilience score closely to assess any potential risks in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Biggest stock gainers today in Hong Kong

Biggest stock losers today in Hong Kong

What is Smartkarma SmartScore?

It is a compound score for a Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores (Value, Dividend, Growth, Resilience, Momentum scores) computed by Smartkarma.

The best stock screener – Smartkarma SmartScore Screener

Smartkarma’s stock screener, Smartkarma SmartScore Screener, allows you to easily discover undervalued gems, high dividend stocks, and high growth stocks, across multiple countries and sectors.

Explore the Smartkarma SmartScore Screener now.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Xiaomi (1810)

52.90 HKD -0.30 (-0.56%) Volume: 144.34M

Xiaomi’s stock price stands at 52.90 HKD, experiencing a slight decrease of -0.56% this trading session, with a robust trading volume of 144.34M. Despite the day’s dip, the tech giant’s stock has shown strong performance with a +53.77% surge YTD, reflecting its solid market position and growth prospects.

Latest developments on Xiaomi

Today, Xiaomi Corp‘s stock price saw movements following a series of key events leading up to this moment. The company’s founder unveiled the first self-developed 3nm system-on-chip, aiming to rival Apple’s A18 Pro. This announcement highlighted Xiaomi’s heavy investment in R&D, including the unveiling of their first SUV. The founder’s emphasis on the new Chinese chip as a competitor to Apple silicon showcased the company’s long-term expansion efforts. These developments have put Xiaomi in the spotlight, attracting attention from investors and tech enthusiasts alike, shaping the stock price movements today.

Xiaomi on Smartkarma

Analysts on Smartkarma are bullish on Xiaomi Corp after the company unveiled its first self-developed 3nm System-on-Chip, the Surge Xuanjie O1, rivaling Apple’s A18 Pro. Caixin Global reports that Xiaomi’s entry into the top tier of smartphone chipmakers marks a significant milestone for the company. The Surge Xuanjie O1, along with the Xuanjie T1 baseband chip, powers Xiaomi’s latest flagship phone 15s Pro, 7Ultra tablet, and smartwatch. The use of TSMC’s advanced 3nm N3E process puts Xiaomi in direct competition with industry giants like Apple and Qualcomm.

Gaudenz Schneider’s analysis on Xiaomi Corp‘s options market reveals high implied and realized volatility, presenting opportunities for calendar spreads and diagonal spreads. The options market favors these spread strategies due to an inverted term structure and slightly negatively sloped skew. With open interest extending to March 2026, there is a balanced interest in both call and put options. Additionally, multi-leg option strategies for Xiaomi Corp showcase a mix of bullish and bearish trades, with a notable presence of self-financing strategies like Diagonal Spreads, highlighting diverse trading approaches in the market.

A look at Xiaomi Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Xiaomi Corp has a positive long-term outlook. The company scored high in Growth, Resilience, and Momentum, indicating strong potential for future expansion and performance. With a focus on innovation and adapting to market trends, Xiaomi is positioned well for continued growth in the communication equipment industry.

While Xiaomi scored lower in Value and Dividend factors, the overall outlook remains optimistic. The company’s emphasis on technological advancements and global marketing strategies have contributed to its strong performance in key areas. Investors may see Xiaomi as a promising investment opportunity based on its high scores in Growth, Resilience, and Momentum.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Alibaba Health Information Technology (241)

4.47 HKD -0.05 (-1.11%) Volume: 128.13M

Alibaba Health Information Technology’s stock price stands at 4.47 HKD, experiencing a slight dip of -1.11% this trading session with a trading volume of 128.13M, yet maintaining a strong YTD performance with a rise of +37.65%, reflecting robust growth potential in the health tech sector.

Latest developments on Alibaba Health Information Technology

Alibaba Health Information Technology Limited recently reported earnings that missed analyst estimates, causing a stir in the market. Investors are closely watching the company’s next moves as analysts adjust their forecasts in response to this news. The stock price of Alibaba Health Information Tec is expected to experience significant movements today as market participants react to the latest developments. Stay tuned for updates on how this event will impact the company’s performance in the coming days.

A look at Alibaba Health Information Technology Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Alibaba Health Information Technology Limited, an integrated healthcare information and content service provider, has received mixed ratings according to the Smartkarma Smart Scores. While the company scored high in growth, resilience, and momentum, it fell short in terms of value and dividend. This suggests a positive long-term outlook for Alibaba Health Information Tec, with strong potential for growth and resilience in the market.

With a focus on leveraging product identification, authentication, and tracking system data for its healthcare information services, Alibaba Health Information Technology Limited is positioned to capitalize on the growing demand for innovative healthcare solutions. The company’s high scores in growth and momentum indicate a promising future, despite lower ratings in value and dividend. Overall, Alibaba Health Information Tec‘s Smartkarma Smart Scores point towards a favorable long-term outlook for the company in the healthcare information sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

CSPC Pharmaceutical Group (1093)

6.63 HKD +0.15 (+2.31%) Volume: 247.04M

CSPC Pharmaceutical Group’s stock price surges to 6.63 HKD, marking a positive session change of +2.31% with a robust trading volume of 247.04M, reflecting a substantial YTD hike of +41.21%.

Latest developments on CSPC Pharmaceutical Group

Investors in CSPC Pharmaceutical Group (HKG:1093) are closely monitoring the company’s recent announcement of a reduction in dividend payments to CN¥0.10. This decision follows a series of key events that have impacted the stock price movements today. The pharmaceutical company has been facing challenges in its market performance, including regulatory changes and competition from generic drug manufacturers. Additionally, recent fluctuations in the global economy have also contributed to the uncertainty surrounding CSPC Pharmaceutical Group‘s future prospects. As a result, investors are keeping a close eye on how these developments will continue to influence the stock price in the coming days.

A look at CSPC Pharmaceutical Group Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, CSPC Pharmaceutical Group shows promising long-term potential. With high scores in Dividend and Momentum, the company demonstrates strong performance in terms of rewarding shareholders and market traction. Additionally, solid scores in Value and Resilience indicate a stable and undervalued position in the market, which could lead to potential growth opportunities. Although the Growth score is not as high as the others, the overall outlook for CSPC Pharmaceutical Group appears positive.

CSPC Pharmaceutical Group Limited, known for its pharmaceutical products such as vitamin C, antibiotics, and generic drugs, is positioned well for long-term success according to the Smartkarma Smart Scores. With a focus on innovation in drug development, the company’s strong performance in Dividend and Momentum reflects its commitment to shareholder value and market competitiveness. With a solid foundation in Value and Resilience, CSPC Pharmaceutical Group is poised for potential growth in the pharmaceutical industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma